Completed over 12,000 cases of robot-assisted clinical
Our Edge Multi-Port Endoscopic Surgical Robot received regulatory approval from the National Medical Products Administration (NMPA) in December 2022 and CE Marking from European Medicines Agency (EMA) in March 2025. As of December 2025, our Edge Multi-Port Endoscopic Surgical Robot is approved in China and Europe across four surgical applications, positioning ourselves to meet a wider range of customer needs, thereby deepening the market penetration of our surgical robots.
• Reliable performance
• Features and Technical Advantages
superb master-slave control experience
• Full-stack technological design
Our Edge Multi-Port Endoscopic Surgical Robot (MP2000 series) adopted a full-stack technological design that seamlessly integrates the on-board robotic system with remote control systems for telesurgery.
• Compatible and Interchangeable Platform
Our Edge Multi-Port Endoscopic Surgical Robot and Edge Single-Port Endoscopic Surgical Robot are compatible and shares the same surgeon’s console and 3DHD visualization system, allowing surgeons to easily switch between the two and facilitates the adoption of both by hospitals.
• Reliable performance
• Features and Technical Advantages
superb master-slave control experience
• Full-stack technological design
Our Edge Multi-Port Endoscopic Surgical Robot (MP2000 series) adopted a full-stack technological design that seamlessly integrates the on-board robotic system with remote control systems for telesurgery.
• Compatible and Interchangeable Platform
Our Edge Multi-Port Endoscopic Surgical Robot and Edge Single-Port Endoscopic Surgical Robot are compatible and shares the same surgeon’s console and 3DHD visualization system, allowing surgeons to easily switch between the two and facilitates the adoption of both by hospitals.




